Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $59.9 million.

  • AdaptHealth's Current Deferred Revenue rose 6699.12% to $59.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.9 million, marking a year-over-year increase of 6699.12%. This contributed to the annual value of $34.9 million for FY2024, which is 940.11% down from last year.
  • AdaptHealth's Current Deferred Revenue amounted to $59.9 million in Q3 2025, which was up 6699.12% from $56.3 million recorded in Q2 2025.
  • Over the past 5 years, AdaptHealth's Current Deferred Revenue peaked at $59.9 million during Q3 2025, and registered a low of $22.3 million during Q3 2021.
  • In the last 5 years, AdaptHealth's Current Deferred Revenue had a median value of $34.0 million in 2024 and averaged $36.1 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first skyrocketed by 18407.14% in 2021, then tumbled by 2529.96% in 2024.
  • Over the past 5 years, AdaptHealth's Current Deferred Revenue (Quarter) stood at $31.4 million in 2021, then rose by 0.86% to $31.6 million in 2022, then increased by 21.9% to $38.6 million in 2023, then decreased by 9.4% to $34.9 million in 2024, then soared by 71.28% to $59.9 million in 2025.
  • Its last three reported values are $59.9 million in Q3 2025, $56.3 million for Q2 2025, and $46.4 million during Q1 2025.